BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

230 hedge funds and large institutions have $2.07B invested in BioCryst Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 93 increasing their positions, 61 reducing their positions, and 36 closing their positions.

Holders
230
Holders Change
-4
Holders Change %
-1.71%
% of All Funds
3.71%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
34
Increased
93
Reduced
61
Closed
36
Calls
$53M
Puts
$22.5M
Net Calls
+$30.6M
Net Calls Change
-$5.65M

Top Buyers

1
AWA
1
Arete Wealth Advisors
Illinois
$271M
2
WP
2
Woodline Partners
California
$23.8M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$22.8M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$23.5M
5
State Street
5
State Street
Massachusetts
$128M

Top Sellers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$0
2
Millennium Management
2
Millennium Management
New York
$181K
3
Victory Capital Management
3
Victory Capital Management
Texas
$29.1M
4
Citadel Advisors
4
Citadel Advisors
Florida
$671K
5
Fisher Asset Management
5
Fisher Asset Management
Washington
$50.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
GKIM
26
GW&K Investment Management
Massachusetts
$19.8M +$3.56M +309,947 +22%
SBH
27
Segall Bryant & Hamill
Illinois
$19.2M -$140K -12,190 -0.7%
Nuveen Asset Management
28
Nuveen Asset Management
Illinois
$18.4M -$3.41M -297,127 -16%
Alkeon Capital Management
29
Alkeon Capital Management
New York
$17.1M +$236K +20,532 +1%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$16.9M +$12.1M +1,051,580 +252%
TCM
31
Tang Capital Management
California
$16.6M +$2.87M +250,000 +21%
Charles Schwab
32
Charles Schwab
California
$16.3M +$393K +34,239 +2%
Nomura Holdings
33
Nomura Holdings
Japan
$15.2M +$12M +1,044,484 +368%
Morgan Stanley
34
Morgan Stanley
New York
$13.3M +$2.83M +246,462 +27%
Norges Bank
35
Norges Bank
Norway
$13.2M +$907K +79,000 +7%
Goldman Sachs
36
Goldman Sachs
New York
$13M -$3.87M -337,461 -23%
Bank of America
37
Bank of America
North Carolina
$11.3M +$1.51M +131,916 +15%
SCM
38
Sarissa Capital Management
Connecticut
$11.3M -$4.71M -410,502 -30%
EP
39
Eversept Partners
New York
$10.1M +$10.1M +880,487 New
Ameriprise
40
Ameriprise
Minnesota
$9.56M +$3.6M +313,623 +60%
JPMorgan Chase & Co
41
JPMorgan Chase & Co
New York
$9.12M +$233K +20,334 +3%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$8.82M +$2.9M +252,845 +49%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$8.81M +$1.6M +138,987 +22%
PAM
44
Panagora Asset Management
Massachusetts
$7.99M +$2.22M +193,020 +38%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$7.77M +$64.4K +5,610 +0.8%
TCM
46
Tekla Capital Management
Massachusetts
$7.72M +$3.71M +323,135 +92%
UBS Group
47
UBS Group
Switzerland
$7.11M +$5.05M +439,894 +245%
Walleye Capital
48
Walleye Capital
New York
$6.95M +$4.18M +364,119 +151%
OIM
49
Oracle Investment Management
Connecticut
$6.72M -$574K -50,000 -8%
Osaic Holdings
50
Osaic Holdings
Arizona
$6.52M -$65K -5,659 -1%
1
2
3 4 5